Health

Results: 481-492 of 7430

Consumers Sound Alarm as WHO COP11 Threatens Harm Reduction

Staloral® Birch Phase III Study Successfully Meets Primary Endpoint, Demonstrating Efficacy in Children and Adolescents

Debiopharm Forges AI-powered Alliance With NetTargets to Pioneer Dual-payload ADCs Against Drug-resistant Cancers

Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory

Novotech Maps Global Growth in Radiopharmaceutical Trials

Sales of Leqembi® totaled 18 billion yen in the third quarter 2025

Thousands with undiagnosed hepatitis and HIV found in A&E testing

Enzymatica AB: Quarterly report Q3/2025: Strong development in Sweden and continued focus on international expansion

Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year

Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results

PR Newswire associated0

Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding its Payload-Linker Platform and Bioconjugate Capabilities

Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results